Explore Prime's climate reporting
Why it exists
What it contains
This report evaluates potential physical and transition climate risks across our business and spanning short‑, medium‑and long‑term time horizons. The report also describes how Prime identifies, assesses and manages them through our enterprise risk management framework.
Specifically, content is organized around key disclosure areas, including governance, strategy, risk management, financial impact and metrics and targets.
Governance
Strategy
Risk management
Metrics and targets
Financial impact
You can find detailed methodologies, assumptions and disclosures within the report.
Frequently asked questions
Disclosure notice
This webpage provides a high‑level overview of Prime Therapeutics’ climate‑related disclosures for informational purposes only. Certain statements may be forward‑looking and subject to risks and uncertainties. California Climate‑Related Risk Disclosure is the authoritative source for Prime’s disclosures prepared in alignment with California SB 261 and the Task Force on Climate‑related Financial Disclosures (TCFD). Prime Therapeutics undertakes no obligation to update this information, except as required by law.
The California Climate‑Related Risk Disclosure report was prepared in partnership with Prime Therapeutics’ trusted sustainability consultants.